09-01-2026
Harnessing Procedural Expertise: KOL Identification for MedTech Advisory Panels
In the MedTech industry, advisory panels play a pivotal role in shaping product innovation, clinical strategy, regulatory readiness, and commercial success. The value of these panels lies in the procedural expertise of their members, including hands-on experience performing specific procedures, using medical devices in real-world settings, and navigating complex clinical workflows.
For example, a cardiologist who routinely performs high-volume transcatheter valve procedures can provide practical feedback on device handling, imaging integration, and workflow efficiency. Similarly, an oncologist actively managing complex treatment pathways can offer insight into diagnostic sequencing, multidisciplinary coordination, and real-world operational considerations. It is this type of hands-on insight that makes advisory input both credible and actionable.
However, as the healthcare landscape continues to expand, identifying the right healthcare experts has become increasingly challenging. Determining who is actively performing relevant procedures, how frequently they do so, and how closely their clinical practice aligns with a Medtech company’s technology is far from straightforward. This is where a structured approach to KOL identification becomes critical.
Enabling Targeted Advisory Selection Through konectar
konectar moves beyond fragmented information and manual validation to enable efficient and precise identification of KOLs for advisory roles. By analyzing multiple data points, it uncovers their professional activities, nuanced relationships and patterns that inform accurate categorization and tiering. By further enabling segmentation based on specialty, subspecialty, geography, and professional focus, Medtech organizations can build more targeted and relevant advisory panels.
So instead of broad shortlists, decision-makers gain access to refined, data-backed clinician profiles, reducing uncertainty and improving strategic fit.
From KOL Identification to Meaningful Engagement
Beyond KOL identification, effective advisory programs depend on structured, ongoing engagement. Advisory panels deliver the greatest value when interactions are intentional and aligned to defined objectives whether for early product design input, clinical evidence generation, market education, or post-launch optimization.
konectar CRM module supports this by helping teams manage interactions in a more organized manner, ensuring engagement histories, discussions, follow-up actions and contract lifecycles are clearly tracked. This leads to more focused conversations, stronger clinical insight, and improved outcomes from advisory initiatives.
Across therapeutic areas, life sciences organizations are adopting more disciplined approaches to KOL strategy. The result is faster decision-making and improved credibility with advisory panels grounded in real-world practice rather than assumptions. So in an environment where expert insight directly influences patient outcomes and commercial performance, this level of precision offers a clear advantage.
Closing Perspective
Harnessing konectar KOL management platform to identify KOLs with strong procedural expertise transforms advisory panels from symbolic gatherings into strategic drivers of innovation. For Medtech companies seeking to reduce risk, improve product–market alignment, and accelerate adoption, a smarter approach to KOL identification and engagement is the natural next step. For more details on how konectar can help you identify the right KOLs for advisory roles, request a demo today!


